Article

Rapid response to chemotherapy in a patient with thymoma with pericardial effusion


 

Thymomas are rare tumors involving the anterior mediastinum. Localized thymomas can be surgically resected and have an excellent prognosis, whereas advanced thymomas are treated with induction chemotherapy followed by surgery. We report here the successful use of chemotherapy in a woman with stage IV thymoma with pericardial infiltration and effusion. Our experience suggests that aggressive chemotherapy with a cisplatin- and adriamycin-based regimen can lead to rapid regression of thymoma and significant improvement in symptoms.

*Click on the link to the left for a PDF of the full article.

Recommended Reading

Idelalisib and rituximab produce responses in 97% with CLL
MDedge Hematology and Oncology
Rituximab plus chlorambucil extend event-free survival in MALT lymphoma
MDedge Hematology and Oncology
Ibrutinib shows promise for CLL del 17p
MDedge Hematology and Oncology
CD30 expression in EBV+ DLBCL confers poor prognosis
MDedge Hematology and Oncology
Pomalidomide plus low-dose dexamethasone may be new standard for MM
MDedge Hematology and Oncology
Early lenalidomide delays progression of smoldering multiple myeloma
MDedge Hematology and Oncology
Immune microenvironment linked to prognosis of follicular lymphoma
MDedge Hematology and Oncology
Diagnosis and Management of Immunoglobulin Light Chain Amyloidosis
MDedge Hematology and Oncology
Pixantrone gaining market access in EU
MDedge Hematology and Oncology
NICE again rejects pixantrone for NHL
MDedge Hematology and Oncology